Skip to main content
Top

12-03-2025 | Gastric Cancer | Research

Development and validation of a nomogram model based on vascular entry sign for predicting lymphovascular invasion in gastric cancer

Authors: Jing Zhang, Peng-Hui Shen, Jun-Bo Wu, Qin Feng, Xiao-Ling Zhang, Rui-Na Jin, Yin-Hao Yang, Mei-Xi Zhou, Wen-Yu Tan, Jian Hou, Qin-Meng Yi, Tian-Mei Hou, Yong-Ai Li, Wen-Qing Hu

Published in: Abdominal Radiology

Login to get access

Abstract

Background

To evaluate the predictive value of a nomogram based on the vascular entry sign for lymphovascular invasion in gastric cancer.

Methods

A total of 135 patients with histopathologically confirmed gastric cancer from August 2021 to November 2022 were enrolled. All patients underwent contrast-enhanced CT scans. Utilizing a random number method, patients were randomly assigned to either a training dataset (n = 96) or a validation dataset (n = 39) in a 7:3 ratio. CT images and clinical characteristics of the patients were collected. Both univariate and multivariate analyses were conducted to identify independent factors influencing lymphovascular invasion in gastric cancer. A nomogram model was developed, and its diagnostic performance and clinical utility were assessed using receiver operating characterist (ROC) curves, calibration curves, and decision curve analysis (DCA).

Results

The multivariate analysis revealed that the vascular entry sign, clinical T stage, and clinical N stage independently influenced the occurrence of factors for lymphovascular invasion in gastric cancer (P < 0.05). A predictive nomogram model was developed for determining LVI status in gastric cancer. The AUC of the nomogram model in the training dataset and validation dataset were 0.878 (95% CI: 0.808–0.948) and 0.866 (95% CI: 0.723-1.000), respectively. The calibration curve and decision curve showed that the model had good reliability and good clinical validity.

Conclusion

The model established based on the factors of vascular entry sign, clinical T stage, and clinical N stage can effectively predict lymphovascular invasion in gastric cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li J, Hu B, Fang L, Gao Y, Shi S, He H, Liu X, Yuan C. Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer. Oncol Lett. 2018;16(5):6488–6494. Li J, Hu B, Fang L, Gao Y, Shi S, He H, Liu X, Yuan C. Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer. Oncol Lett. 2018;16(5):6488–6494.
2.
go back to reference Lu J, Dai Y, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, Li P, Huang CA-OX. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution. BMC Cancer. 2019;19(1):216. Lu J, Dai Y, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, Li P, Huang CA-OX. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution. BMC Cancer. 2019;19(1):216.
3.
go back to reference Mei D, Zhao B, Zhang J, Luo R, Lu H, Xu H, Huang B. Impact of Lymphovascular Invasion on Survival Outcome in Patients With Gastric Cancer. Am J Clin Pathol. 2020;153(6):833–841. Mei D, Zhao B, Zhang J, Luo R, Lu H, Xu H, Huang B. Impact of Lymphovascular Invasion on Survival Outcome in Patients With Gastric Cancer. Am J Clin Pathol. 2020;153(6):833–841.
4.
go back to reference Jing Z, Yongai L, Liang Z, Junbo W, Yu G, Kangjia D, Huijie G, Ning X. Diagnostic value of enhanced CT vascular-entry sign for lymphovascular invasion of gastric cancer. Chinese Journal Digestive Surgery, 2024, 23(3):414–421. Jing Z, Yongai L, Liang Z, Junbo W, Yu G, Kangjia D, Huijie G, Ning X. Diagnostic value of enhanced CT vascular-entry sign for lymphovascular invasion of gastric cancer. Chinese Journal Digestive Surgery, 2024, 23(3):414–421.
5.
go back to reference Fujikawa H, Koumori K, Watanabe H, Kano K, Shimoda Y, Aoyama T, Yamada T, Hiroshi T, Yamamoto N, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. The Clinical Significance of Lymphovascular Invasion in Gastric Cancer. In Vivo. 2020;34(3):1533–1539. Fujikawa H, Koumori K, Watanabe H, Kano K, Shimoda Y, Aoyama T, Yamada T, Hiroshi T, Yamamoto N, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. The Clinical Significance of Lymphovascular Invasion in Gastric Cancer. In Vivo. 2020;34(3):1533–1539.
6.
go back to reference Wang FA-OH, Zhang XT, Tang L, Wu Q, Cai MA-OY, Li YA-OF, Qu XJ, Qiu H, Zhang YJ, Ying JA-OE, Zhang JA-O, Sun LY, Lin RA-OB, Wang CA-O, Liu H, Qiu MA-OZ, Guan WL, Rao SX, Ji JF, Xin Y, Sheng WQ, Xu HA-OM, Zhou ZW, Zhou AP, Jin J, Yuan XL, Bi FA-O, Liu TS, Liang HA-O, Zhang YQ, Li GX, Liang J, Liu BR, Shen LA-O, Li J, Xu RA-OH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond). 2024;44(1):127–172. Wang FA-OH, Zhang XT, Tang L, Wu Q, Cai MA-OY, Li YA-OF, Qu XJ, Qiu H, Zhang YJ, Ying JA-OE, Zhang JA-O, Sun LY, Lin RA-OB, Wang CA-O, Liu H, Qiu MA-OZ, Guan WL, Rao SX, Ji JF, Xin Y, Sheng WQ, Xu HA-OM, Zhou ZW, Zhou AP, Jin J, Yuan XL, Bi FA-O, Liu TS, Liang HA-O, Zhang YQ, Li GX, Liang J, Liu BR, Shen LA-O, Li J, Xu RA-OH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond). 2024;44(1):127–172.
7.
go back to reference Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer. 2015;15:370. Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer. 2015;15:370.
8.
go back to reference Ren T, Zhang W, Li S, Deng L, Xue C, Li Z, Liu S, Sun J, Zhou J. Combination of clinical and spectral-CT parameters for predicting lymphovascular and perineural invasion in gastric cancer. Diagn Interv Imaging. 2022;103(12):584–593. Ren T, Zhang W, Li S, Deng L, Xue C, Li Z, Liu S, Sun J, Zhou J. Combination of clinical and spectral-CT parameters for predicting lymphovascular and perineural invasion in gastric cancer. Diagn Interv Imaging. 2022;103(12):584–593.
9.
go back to reference Li Q, Feng QX, Qi L, Liu C, Zhang J, Yang G, Zhang YD, Liu XA-O. Prognostic aspects of lymphovascular invasion in localized gastric cancer: new insights into the radiomics and deep transfer learning from contrast-enhanced CT imaging. Abdom Radiol (NY). 2022;47(2):496–507. Li Q, Feng QX, Qi L, Liu C, Zhang J, Yang G, Zhang YD, Liu XA-O. Prognostic aspects of lymphovascular invasion in localized gastric cancer: new insights into the radiomics and deep transfer learning from contrast-enhanced CT imaging. Abdom Radiol (NY). 2022;47(2):496–507.
10.
go back to reference Yardımcı AH, Koçak B, Turan Bektaş C, Sel İ, Yarıkkaya E, Dursun N, Bektaş H, Usul Afşar Ç, Gürsu RU, Kılıçkesmez Ö. Tubular gastric adenocarcinoma: machine learning-based CT texture analysis for predicting lymphovascular and perineural invasion. Diagn Interv Radiol. 2020;26(6):515–522. Yardımcı AH, Koçak B, Turan Bektaş C, Sel İ, Yarıkkaya E, Dursun N, Bektaş H, Usul Afşar Ç, Gürsu RU, Kılıçkesmez Ö. Tubular gastric adenocarcinoma: machine learning-based CT texture analysis for predicting lymphovascular and perineural invasion. Diagn Interv Radiol. 2020;26(6):515–522.
11.
go back to reference Fan L, Li J, Zhang H, Yin H, Zhang R, Zhang J, Chen X. Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables. Abdom Radiol (NY). 2022;47(4):1209–1222. Fan L, Li J, Zhang H, Yin H, Zhang R, Zhang J, Chen X. Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables. Abdom Radiol (NY). 2022;47(4):1209–1222.
12.
go back to reference Chen X, Yang Z, Yang J, Liao Y, Pang P, Fan W, Chen X. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study. Cancer Imaging. 2020;20(1):24. Chen X, Yang Z, Yang J, Liao Y, Pang P, Fan W, Chen X. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study. Cancer Imaging. 2020;20(1):24.
13.
go back to reference Ma Z, Liang C, Huang Y, He L, Liang C, Chen X, Huang X, Xiong Y, Liu Z. Can lymphovascular invasion be predicted by preoperative multiphasic dynamic CT in patients with advanced gastric cancer? Eur Radiol. 2017;27(8):3383–3391. Ma Z, Liang C, Huang Y, He L, Liang C, Chen X, Huang X, Xiong Y, Liu Z. Can lymphovascular invasion be predicted by preoperative multiphasic dynamic CT in patients with advanced gastric cancer? Eur Radiol. 2017;27(8):3383–3391.
14.
go back to reference Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017;17(1):737. Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017;17(1):737.
15.
go back to reference You MA-O, Park SA-O, Kang HA-O, Lee DA-O. Radiologic serosal invasion sign as a new criterion of T4a gastric cancer on computed tomography: diagnostic performance and prognostic significance in patients with advanced gastric cancer. Abdom Radiol (NY). 2020;45(10):2950–2959. You MA-O, Park SA-O, Kang HA-O, Lee DA-O. Radiologic serosal invasion sign as a new criterion of T4a gastric cancer on computed tomography: diagnostic performance and prognostic significance in patients with advanced gastric cancer. Abdom Radiol (NY). 2020;45(10):2950–2959.
16.
go back to reference Wang P, Chen K, Han Y, Zhao M, Abiyasi N, Peng H, Yan S, Shang J, Shang N, Meng WA-O. Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patients. Future Oncol. 2023;19(23):1613–1626. Wang P, Chen K, Han Y, Zhao M, Abiyasi N, Peng H, Yan S, Shang J, Shang N, Meng WA-O. Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patients. Future Oncol. 2023;19(23):1613–1626.
17.
go back to reference Ma Z, Liang C, Huang Y, He L, Liang C, Chen X, Huang X, Xiong Y, Liu Z. Can lymphovascular invasion be predicted by preoperative multiphasic dynamic CT in patients with advanced gastric cancer? European radiology, 2017, 27(8):3383–3391.CrossRefPubMed Ma Z, Liang C, Huang Y, He L, Liang C, Chen X, Huang X, Xiong Y, Liu Z. Can lymphovascular invasion be predicted by preoperative multiphasic dynamic CT in patients with advanced gastric cancer? European radiology, 2017, 27(8):3383–3391.CrossRefPubMed
18.
go back to reference Kambara Y, Miyake H, Nagai H, Yoshioka Y, Shibata K, Asai S, Yuasa N. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer. Eur J Surg Oncol. 2020;46(10 Pt A):1918–1924. Kambara Y, Miyake H, Nagai H, Yoshioka Y, Shibata K, Asai S, Yuasa N. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer. Eur J Surg Oncol. 2020;46(10 Pt A):1918–1924.
19.
go back to reference Ma X, Zhou X, Guo J, Feng X, Zhao M, Zhang P, Zhang C, Gong S, Wu N, Zhang Y, Zhang X, Ren Z, Zhang P. CA19–9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy. BMC Surg. 2024;24(1):31. Ma X, Zhou X, Guo J, Feng X, Zhao M, Zhang P, Zhang C, Gong S, Wu N, Zhang Y, Zhang X, Ren Z, Zhang P. CA19–9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy. BMC Surg. 2024;24(1):31.
20.
go back to reference Okubo K, Arigami T, Matsushita D, Uenosono Y, Yanagita S, Kijima T, Tsuruda Y, Noda M, Sasaki K, Mori S, Kurahara H, Ohtsuka T. The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer. Anticancer Res. 2021;41(11):5643–5649. Okubo K, Arigami T, Matsushita D, Uenosono Y, Yanagita S, Kijima T, Tsuruda Y, Noda M, Sasaki K, Mori S, Kurahara H, Ohtsuka T. The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer. Anticancer Res. 2021;41(11):5643–5649.
21.
go back to reference Xu YQ, Jiang TW, Cui YH, Zhao YL, Qiu LQ. Prognostic value of ABO blood group in patients with gastric cancer. J Surg Res, 2016, 201(1):188–195.CrossRefPubMed Xu YQ, Jiang TW, Cui YH, Zhao YL, Qiu LQ. Prognostic value of ABO blood group in patients with gastric cancer. J Surg Res, 2016, 201(1):188–195.CrossRefPubMed
22.
go back to reference Sun XJ, Ai L, Feng YC. The Value of ABO Blood Group and Complete Blood Count for the Prognosis Analysis of Gastric Cancer Patients. Onco Targets Ther, 2020, 13:4627–4633.CrossRefPubMedPubMedCentral Sun XJ, Ai L, Feng YC. The Value of ABO Blood Group and Complete Blood Count for the Prognosis Analysis of Gastric Cancer Patients. Onco Targets Ther, 2020, 13:4627–4633.CrossRefPubMedPubMedCentral
23.
go back to reference Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood transfusion = Trasfusione del sangue, 2016, 14(5):434–440.PubMedPubMedCentral Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood transfusion = Trasfusione del sangue, 2016, 14(5):434–440.PubMedPubMedCentral
Metadata
Title
Development and validation of a nomogram model based on vascular entry sign for predicting lymphovascular invasion in gastric cancer
Authors
Jing Zhang
Peng-Hui Shen
Jun-Bo Wu
Qin Feng
Xiao-Ling Zhang
Rui-Na Jin
Yin-Hao Yang
Mei-Xi Zhou
Wen-Yu Tan
Jian Hou
Qin-Meng Yi
Tian-Mei Hou
Yong-Ai Li
Wen-Qing Hu
Publication date
12-03-2025
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-025-04812-3

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video